Aclara BioSciences Inc., of Mountain View, Calif., elected to its board of directors Andre Marion, a founder of Applied Biosystems.

Acorda Therapeutics, of Hawthorne, N.Y., named Mitchell Katz senior director, clinical programs.

Albany Molecular Research Inc., of Albany, N.Y., elected to its board of directors Kevin O'Connor, president of Albany's Center for Economic Growth.

Amersham Pharmacia Biotech, of London, appointed Mike Hayes senior vice president of research and development.

Astex Technology Ltd., of London, named Simon Campbell non-executive director.

Athersys Inc., of Cleveland, named James Shook executive vice president of product development and regulatory affairs.

Aviron, of Mountain View, Calif., elected to is board of directors Dennis Fenton, executive vice president of Amgen Inc. and Wayne Hockmeyer, chairman and CEO of MedImmune Inc.

BioChem Pharma Inc., of Laval, Quebec, named Peter McBride vice president, communications and investor relations.

Biotechnology Industry Organization, of Washington, named Lisa Dry director of communications representing foods and crops.

Cambridge Heart Inc., of Bedford, Mass., elected to its board of directors Maren Anderson, a founding partner of Covance Health Economics and Outcomes Services, of Washington

Cepheid, of Sunnyvale, Calif., elected to its board of directors Ernest Mario, chairman and chief executive officer of Alza Corp.

Cyberonics Inc., of Houston, named Leonard Milke vice president, marketing.

Cytran Inc., of Seattle, named Moise Khayrallah senior director of clinical affairs, and Beatrice Langton-Webster senior director of preclinical research.

Discovery Laboratories Inc., of Doylestown, Pa., named Milton Packer a distinguished clinical adviser for its scientific advisory board. Packer is chairman of the FDA's Cardio-Renal Advisory Committee.

Edwards Lifesciences Corp., of Irvine, Calif., named to its board of directors Mike Bowlin, chairman and CEO of Atlantic Richfield Co., and Victoria Fash, president and CEO of IMS Health.

EluSys Therapeutics Inc., of Pine Brook, N.J., appointed Linda Nardone vice president of clinical and regulatory affairs.

Endorex Corp., of Chicago, named Frank Reid vice president, finance and corporate development.

Exelixis Inc., of South San Francisco, named Michael Morrissey vice president, discovery research; Michael Rusnak vice president, pharmaceutical business development; E. Kristine McClintock controller; Lisa Benthein director of human resources; and Angela Bitting associate director, corporate communications.